BioCentury
ARTICLE | Clinical News

Micardis telmisartan: Additional Phase IV data

October 27, 2008 7:00 AM UTC

Additional data from the double-blind, international Phase IV ONTARGET trial showed that 80 mg of Micardis was as efficacious, and significantly better tolerated, than 10 mg ramipril in a subgroup of ...